Abstract
The anergy which is associated with trauma, burn injury and sepsis shares similarities with the pharmacologically induced immunosuppression of organ transplant patients. These patients have the same high risk of infections which also causes mortality as in the trauma and burn patients. The increased risk of infection in transplant patients is mainly due to prednisone, although both azathioprine, an inhibitor of DNA replication, and cyclosporin A, an inhibitor of interleukin 2 (IL-2) formation, may play some role in the increased incidence of infection. The immunodeficiency characteristic of burn patient has been suggested to be mediated by a deficiency in IL-2 production. This may however only be a partial explanation since patients treated with CsA do not seem to have a substantial increased risk of infections although they are immunosuppressed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antonacci, A.C., Good, R.A., and Gupta, S.: T-cell subpopulations following thermal injury. Surgery, Gynecology and Obstetrics 155:1 (1982).
Snyder, D.S., and Unanue, E.R.: Corticosteroids inhibit murine macrophage la expression and interleukin 1 production. J. Immunol.129:1803 (1982).
Kronke, M., Leonard, W.J., Depper, J. et al.: Cyclosporin A inhibits T-cell growth factor gene expression at the level mRNA transcription. Proc. Nat. Acad. Sci. 81:5214 (1984).
Braquet, M, Lavaud, P., Dormont, D. et al.: Leukocytic function in burn-injured patients. Prostaglandins 29:747 (1985).
Drath, D.B., and Kahan B.D.: Phagocytic cell function in response to immunosuppressive therapy. Arch. Surg. 119:156 (1984).
Foegh, M.L., Alijani, M.R., Helfrich, G.B., and Ramwell, P.W.: Eicosanoids and organ transplantation. Ann. Clin. Res. 16:318 (1984).
Foegh, M.L., Khirabadi, B.S., Rowles, J.R., Braquet, P., and Ramwell, P.W.: Inhibition of PAF and leukotriene expression in acute cardiac allograft rejection in rats. Pharmacol. Res. Commun.
Foegh, M.L., Khirabadi, B.S., Braquet, P., and Ramwell, P.W.: Prolongation of cardiac allograft survival with BN 52021, a specific antagonist of platelet—activating factor. Transplantation 42:86 (1986).
Foegh ML, Khirabadi BS, and Ramwell PW: Prolongation of experimental cardiac allograft survival with thromboxane related drugs. Transplantation 40:124 (1985).
Foegh, M.L., Cooley, C., Helfrich, G.B. et al.: Urine i-TXB2 in renal allograft rejection. Lancet 2:431 (1981).
Steinhauer, H.B., Wilms, H., Ruther, M., and Schollmeyer, P.: Clinical experience with urine Thromboxane B2 in acute renal allograft rejection. Transpl. Proc. 18 (suppl. 4):98 (1986).
Hirata, F., Schiffman, E., Venkatasubramanian, K., Solomon D., and Axelrod, J.: A phosphplopase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc. Nat. Acad. Sci. 77:2533 (1980).
Calne, R.Y.: Inhibition of the rejection of renal homografts in dogs by purine analogues. Transplant. Bull. 28:65 (1961).
Neild, G., Rocchi, G., Imberti, L., et al.: Effect of cyclosporine on prostacyclin synthesis by vascular tissue. Thromb. Res. 32:373 (1983).
Fan, T.-P.D., and Lewis, G.P.: Mechanism of cyclosporin A induced inhibition of prostacyclin synthesis by macrophages. Prostaglandins 30:735 (1985).
Farrar, W.L., and Humes, J.L.: The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. J. Immunol. 135:1153 (1985).
Rapaport, R.S., and Dodge, G.R.: Prostaglandin inhibits the production of human interleukin 2. J. Exp. Med. 155:943 (1982).
Dinarello, C.A., Monnoy, S.O., and Rosenwasser, L.J.: Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte activating factor/interleukin 1. J. Immunol. 130:890 (1983).
Rola-Pleszczynski, M., and Gagnon, L.: Natural killer cell function modulated by leukotriene B4: mechanism of action. Transplant. Proc. 18 (suppl. 4):44 (1986).
Goodwin, J.S.: Role of leukotriene B4 in T-cell activation. Transpl. Proc. 18 (suppl. 4):49 (1986).
Payan, D.G., and Goetzl, E.J.: Specific supppression of human T-lymphocyte function by leukotriene B4. J. Immunnol. 131:551 (1983).
Goodwinn, J.S., Atluru, D., Sierakowski, S., and Lianos, E. A.: Mechanism of action of glucocorticoids. Inhibition of T-cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4. J. Clin. Invest. 77:1244 (1986).
Payan, D.G., and Goetzl, E.J.: The dependence of human T-lymphocyte migration of the 5-lipoxygenation of endogenous arachidonic acid. J. Clin. Immunol. 1:266 (1981).
Kelly, J.P., Johnson, M.C., Parker, C.W.,: Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygeenase pathway. J. Immunol. 122:1572 (1979).
Foegh, M.L., Maddox, Y.T., and Ramwell, P.W.: Human peritoneal eosiniphils and formation of arachidonate cyclooxygenase products. Scand. J. Immunol. 23:599 (1986).
Ceuppens, J.L., Vertessen, S., Deckmyn, H., and Vermylen, J.: Effect of thromboxane A2 on lymphocyte proliferation. Cell. Immunol. 90:458 (1985).
Johnson, H.M., and Torres, B.A.: Leukotrienes: positive signals for regulation of gamma-interferon production. J. Immunol. 132:413 (1984).
Snyder, D.S., Beller, D.I., and Unanue, E.R.: Prostaglandins modulate macrophage la expression. Nature 299:163 (1982).
Snyder, D.S., and Unanue, E.R.: Corticosteroids inhibit murine macrophage la expression and interleukin 1 production. J. Immunol. 129:1803 (1982).
Basham, T.Y., and Merigan, T.C.: Recombinant interferon-gamma increases HLA-DR synthesis and expression. J. Immunol. 130:1492 (1983).
Foegh, M.L., Khirabadi, B.S., and Ramwell, P.W.: Improved ratr cardiac allograft survival with non-steroidal pharmacologic agents related to eicosanoids. Transpi. Proc. In press.
Serhan, C.N., Hamberg, M., Ramstedt, U., and Samuelsson, B.: Lipoxins: stereochemistry, biosynthesis and biological activities. Adv. Prostagl. Thrombox. Leukotr. Res. 16:83 (1986).
Rokash, J., and Fitzsimmons, B.: Lipoxins do they have a biological role? Transpl Proc 18 (suppl. 4):7 (1986).
Foegh, M.L., Hartmann, D.-P., Rowles, J.R. et al.: Leukotrienes, thromboxane and PAF in organ transplantation. Adv. Prostagl. Thrombox. Leukotr. Res. 17:144 (1987).
Foegh, M.L., Braquet, P, Khirabadi, B.S., Rowles, J.R., and Ramwell, P.W.: Inhibition of PAF and leukotriene expression in acute cardiac allograft rejection in rats. Biochem. Res. Comm 18:127 (1986).
Foegh, M.L., Alijani, M.R., Helfrich, G.B., Khirabadi, B.S., Schreiner, G.E., and Ramwell, P.W.: In: Prostaglandins Leukotrienes Lipoxins, Bailey M (ed) New York, Plenum Press, 1985.
Quagliata, F., Lawrence, V.J.W., and Philips-Quagliata, J.M.: Prostaglandin E-, as a regulator of lymphocyte function. Cell. Immunol. 6:457 (1973).
Anderson C.B., Jaffe, B.M., and Graff, R.J.: Prolongation of murine skin allografts by prostaglandin E. Transplantation 23:244 (1977).
Mertin, J., and Hunt, R.: Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice. Proc. Natl. Acad. Sci. 73:928 (1976).
Franks, D.J., MacManus, J.P., and Whitfield, J.F.: The effect of prostaglandins on cyclic AMP production and cell proliferation in thymic lymphocytes. Biochem. Biophys. Res. Commun. 44:1177 (1971).
Maddox, Y.T., Foegh, M.L., Zeligs, B., Bellanti, J. Zmudka, M., Ramwell, P.W.: A routine source of human peritoneal macrophages. Scand. J. Immunol. 19:23 (1984).
Van Epps, D.: Suppression of human lymphocyte migration by PGE2 Inflammation 5:81 (1981).
Strom, T.B., Carpenter, C.B.: Prostaglandin as an effective antirejection therapy in rat renal allograft recipients. Transplantation 35:279 (1983).
Rowles, J.R., Foegh, M.L., Khirabadi, B.S., and Ramwell, P.W.:The synergistic effect of cyclosporine and iloprost on survival of rat cardiac allografts. Transplantation 42:94 (1986).
Ito, S., Camussi, G., Tetta, C., Milgrom, F., and Andres, G.: Hyperacute renal allograft rejection in the rabbit. Lab. Invest. 51:148 (1984).
Khirabadi, B.S., Foegh, M.L., and Ramwell, P.W.: Urine immunoreactive thromboxane B2 in rat cardiac allograft rejection. Transplantation 39:6 (1985).
Foegh, M.L., Alijani, M.R., Helfrich, G.B., et al.:Thromboxane and leukotrienes in clinical and experimental transplant rejection. Adv. Prostagl. Thrombox. Leukotr. Res. 13:209 (1985).
Foegh, M.L., Eliasen, K., Johansen, S., Helfrich, B.G., and Ramwell, P.W.: Coronary artery thrombosis and elevated urine immunoreactive thromboxane B2. Prostaglandins 32:781 (1986).
Foegh, M.L., Alijani, M.R., Helfrich, G.B., Khirabadi, B.S., Lim, K., and Ramwell, P.W.: Lipid mediators in organ transplantation. Transplant. Proc. 18 (suppl. 4):20 (1986).
Kawagushi, A., Goldman, M.H., Shapiro, R., et al.: Increase in urinary thromboxane B2 in rats caused by cyclosporine. Transplantation 40:214 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this paper
Cite this paper
Foegh, M.L., Alijani, M.R., Helfrich, G.B., Khirabadi, B.S., Lim, K., Ramwell, P.W. (1987). Elective Immunosuppression. In: Paubert-Braquet, M., Braquet, P., Demling, B., Fletcher, J.R., Foegh, M. (eds) Lipid Mediators in the Immunology of Shock. NATO ASI Series, vol 139. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0919-2_43
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0919-2_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8245-7
Online ISBN: 978-1-4613-0919-2
eBook Packages: Springer Book Archive